Assertio Holdings Inc (ASRT)
1.01
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
1.01
0.00 (0.00%)
After-Hours: 16:31
Assertio Holdings Price to Book Value: 0.7144 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 14, 2024 | 0.7144 |
May 13, 2024 | 0.7426 |
May 10, 2024 | 0.679 |
May 09, 2024 | 0.7426 |
May 08, 2024 | 0.7462 |
May 07, 2024 | 0.7851 |
May 06, 2024 | 0.8629 |
May 03, 2024 | 0.7285 |
May 02, 2024 | 0.7144 |
May 01, 2024 | 0.6515 |
April 30, 2024 | 0.626 |
April 29, 2024 | 0.5998 |
April 26, 2024 | 0.5858 |
April 25, 2024 | 0.5553 |
April 24, 2024 | 0.6122 |
April 23, 2024 | 0.6433 |
April 22, 2024 | 0.612 |
April 19, 2024 | 0.5467 |
April 18, 2024 | 0.5333 |
April 17, 2024 | 0.5517 |
April 16, 2024 | 0.5628 |
April 15, 2024 | 0.576 |
April 12, 2024 | 0.614 |
April 11, 2024 | 0.624 |
April 10, 2024 | 0.6349 |
Date | Value |
---|---|
April 09, 2024 | 0.6416 |
April 08, 2024 | 0.6526 |
April 05, 2024 | 0.6703 |
April 04, 2024 | 0.6529 |
April 03, 2024 | 0.6537 |
April 02, 2024 | 0.6574 |
April 01, 2024 | 0.6619 |
March 31, 2024 | |
March 28, 2024 | 0.6603 |
March 27, 2024 | 0.6815 |
March 26, 2024 | 0.7021 |
March 25, 2024 | 0.7159 |
March 22, 2024 | 0.7159 |
March 21, 2024 | 0.7228 |
March 20, 2024 | 0.7159 |
March 19, 2024 | 0.6952 |
March 18, 2024 | 0.7159 |
March 15, 2024 | 0.771 |
March 14, 2024 | 0.7503 |
March 13, 2024 | 0.7847 |
March 12, 2024 | 0.6952 |
March 11, 2024 | 0.6434 |
March 08, 2024 | 0.6276 |
March 07, 2024 | 0.6276 |
March 06, 2024 | 0.6126 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2285
Minimum
Dec 05 2019
3.755
Maximum
Feb 16 2021
0.9892
Average
0.9625
Median
Price to Book Value Benchmarks
Ocular Therapeutix Inc | 2.392 |
Vertex Pharmaceuticals Inc | 6.090 |
Cormedix Inc | 4.964 |
Verastem Inc | 13.30 |
CytomX Therapeutics Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 0.6075 |
Price to Free Cash Flow | 2.509 |
Price | 1.01 |
Earnings Yield | -362.4% |
Market Cap | 96.08M |